In summary, our results establish that p38 MAPK/c-jun signaling is responsible for the increase of MMP-9 by ATO, and suggest a central role for HMOX1 in the modulation of this pathway and in the apoptotic response of CLL cells to ATO. This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.